MP
AMED

Mangrove Partners’s Amedisys AMED Stock Holding History

Mangrove Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-264,826
Closed -$24.3M – 163
2024
Q2 		$24.3M Hold
264,826
– – 1.86% 20
2024
Q1 		$24.4M Buy
264,826
+95,192
+56% +$8.92M 1.7% 22
2023
Q4 		$16.1M Buy
+169,634
New +$15.8M 1.09% 29
2016
Q1 		– Sell
-40,400
Closed -$1.59M – 40
2015
Q4 		$1.59M Hold
40,400
– – 0.39% 36
2015
Q3 		$1.53M Buy
40,400
+3,949
+11% +$167K 0.35% 37
2015
Q2 		$1.45M Hold
36,451
– – 0.36% 37
2015
Q1 		$976K Hold
36,451
– – 0.24% 40
2014
Q4 		$1.07M Buy
+36,451
New +$900K 0.3% 36

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Mangrove Partners's AMED Position: Q3 2024 in Review

Mangrove Partners sold out of Amedisys (AMED) in Q3 2024, closing a stake of 264,826 shares — an estimated $24.3M sold.

Mangrove Partners first reported a position in AMED in Q4 2014 and held it in 8 quarters. The position peaked at $24.4M in Q1 2024. 285 funds tracked by Wall St. Rank hold AMED as of Q3 2024.

  • Mangrove Partners reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
  • Mangrove Partners sold 264,826 Amedisys shares in Q3 2024, an estimated $24.3M.
  • Mangrove Partners first reported a position in Amedisys in Q4 2014 and held it in 8 quarters.
  • Mangrove Partners's Amedisys position peaked at $24.4M in Q1 2024.
  • 285 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.

Based on Mangrove Partners's 13F filing for Q3 2024, filed 14 Nov 2024.